Elevance Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Elevance Health, Inc. on October 25, 2022, reporting an event that occurred on October 24, 2022. The filing pertains to corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
The primary material change reported is the election of Deanna Strable-Soethout to the Board of Directors, effective November 1, 2022. Her term will expire at the 2023 annual meeting of shareholders. Additionally, she has been appointed to the Audit and Governance Committees.
Management Commentary and Governance Details
- Qualifications: The Board determined that Ms. Strable-Soethout qualifies as an "audit committee financial expert."
- Independence: There are no arrangements or understandings regarding her election, and she holds no direct or indirect material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.
- Compensation: She will receive compensation in accordance with the Company's standard program for non-employee directors, as detailed in Exhibit 10.7 of the Form 10-Q for the quarter ended June 30, 2022.
Investor Verification Checklist
- Verify the effective date of the new director's term (November 1, 2022).
- Review the standard compensation program for non-employee directors referenced in the June 30, 2022 Form 10-Q.
- Confirm the specific responsibilities assigned to the Audit and Governance Committees.
- Check for any subsequent filings regarding the 2023 annual meeting of shareholders.